{"name":"Yellow Jersey Therapeutics AG","slug":"yellow-jersey-therapeutics-ag","ticker":"","exchange":"","domain":"","description":"Yellow Jersey Therapeutics AG is a biotechnology company focused on developing innovative treatments in the field of infectious diseases. The company's lead candidate, NM26-2198, was discontinued, and they are currently exploring new opportunities to advance their pipeline.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNMF9iLUNCQmR1QU1zM2w0dVZZYld1b3BscGxCMkpSUENWTllCbGtPek1jUVlsTmVBU0JQNTB3V1FCWHY3c1V6M0VsUmdmNXhwWmo0dmN6b2U1LWVONm9DNDN2eTVscEljdTlhZHc3c3I2Q0tITjB3RHE3V1E5V0ZlOE04NFAwTzdqNmEyeEZ2bElUTExQaVlham5oQUlCZ0xLWC1KM2dB?oc=5","date":"2026-01-28","type":"pipeline","source":"BioWorld News","summary":"Boehringer nabs preclinical IBD bispecific in $1.2B Simcere pact - BioWorld News","headline":"Boehringer nabs preclinical IBD bispecific in $1.2B Simcere pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1ZMUhWRDFXQ2dSczU3dFNpYkw5c0hxSUZsVU9OUTNSZkhFcTFRZ1VhRm5WOWp2WU5XZ1huRVhjcjYxU09uR2ZXTDN6dTZBWmo5aFNsWVVkQkhiSndhVUhwdTlYQ0dXWk5tSVZBQzRwQzAzLTlVMjB5QWQ3aFJsTkU?oc=5","date":"2025-01-09","type":"pipeline","source":"Startupticker.ch","summary":"Numab raises additional CHF50 million - Startupticker.ch","headline":"Numab raises additional CHF50 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPMng4bVlqTnlGakxZdTA2OE1WY2txeFNjVmYwM0RmOGUyeVBDa3JBUUdxVHNXWC1HaTlVeGVzLThYS0pQblVlbFZfeXAwN0RKclI5WUFEMTR6OTh6R0puN0hqTmlqa01YSXlKVVM5Q1YzSXpMX1RQRjE1SjNFbVhjUGRoUk1oempIM21tSktuNFRYQkJ2MWZEekJRekRCb3Z3RnpyUGRwTzBtYmRjOHNuNWw0dzg?oc=5","date":"2024-12-19","type":"deal","source":"Intellizence","summary":"Mergers & Acquisitions by Top Biotechnology Companies – 2024 - Intellizence","headline":"Mergers & Acquisitions by Top Biotechnology Companies – 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQUnRERElsMElTa3hNSXI0dllLdnhVTE55TmZJNy1Eb0dvdVNUbVVSc2JRel9yX2luQjRrSEU1eXN4LVJsZHBQM2JvR2dRdklTTkJfaDJ4Z1ZySnhNSGxNY0xaX3EwdEYybkNXdWM5Y3FGYnM0cHE1ZGpMZWNwVGd6OFhNNVNleGpKSkFvQU85cGE0N1B5dlR3azIwOEdteU1IYmZlLTBvX05sSkZTcHpB?oc=5","date":"2024-11-15","type":"deal","source":"Fierce Biotech","summary":"Biotechs behind J&J-bought Yellow Jersey partner on another immunology asset - Fierce Biotech","headline":"Biotechs behind J&J-bought Yellow Jersey partner on another immunology asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPT1pOejRIWE8taEd6eGJPQU1PS0VxajFOdUlyZ042am1JdVU0NzUwSV82QWlQZTRpbGhhZWdqRFFqRDJFTVhlcEVvOEM2UU5kWWdJdGc2M2x5dzhqTEtZQlcxN0FpdW1qR2c5eVBuVzNJUUxWQ25xQVUtbm85c2xIa3BGd0EtMEZhZng0a19KdzI4WmpaREFUNEtVOWFWeTZYQXRmZEJHNVZreTlXS3RLX09qanJvVjFMYVFiQkVKU1V6Rzd4bzlUYkxWTDFOSkxjV1loanRuQUh4YzRtZVg5TXVZekpuXzF1dUcwTF90TWlseE1KMkpOSjdRMzQ3aVZZOVVoMWJ0b1pHR1YtaG81TEhfLXRfNURGVmpOSWdnMlh3ZXJkblEzLUlwMUNVZ3ZacWJkU3hBb3hWZDI5TDJwd2NqUmQwbkh3ZmswNnZDWjFuandi?oc=5","date":"2024-11-15","type":"pipeline","source":"GlobeNewswire","summary":"Numab Therapeutics and Kaken Pharmaceutical Enter - GlobeNewswire","headline":"Numab Therapeutics and Kaken Pharmaceutical Enter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNd0FON2tnWHFpTGJtQ3lMZW5OTTBOQUluNll4YkxfRlJ3TFE4M2RfUm10bjVJM3dfb2ZCOHhkMDNtb1QwMmVJenVJNmFwY0phd2JOSXBLQWQ3OXFqb0psbU9idzNkNFRpV1h4YW9ZUGhvWkR2SXZ6ZXprT0FSNHowVWFXV1pTajVQejdXejllQkhIbTN1SFE?oc=5","date":"2024-05-31","type":"pipeline","source":"Switzerland Global Enterprise (S-GE)","summary":"Numab Therapeutics sells subsidiary to Johnson & Johnson - Switzerland Global Enterprise (S-GE)","headline":"Numab Therapeutics sells subsidiary to Johnson & Johnson - Switzerland Global Enterprise (S-GE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQeG9pRDd3NVFSRjFrMjdsdVFWMUhuWm0yWUVpWm1YdWM0ZFJNMGU1SFZsSG5ReXkwSGFKd3BtejAtd1ZGNDVKRzhGVGRYbTRHUHctV3Jxb2t4TS1xOTREWVBjdEsxZDRqeU5SOXotX1k0WWg2QVROT1JHUWQ0UTBSWGxVUkJnM293U2cwQjVFVk1jc3NiaUctZWZKYjUxby1jQmVyLXFTWUgxRWlyUVpFTVFkRDVLUTVWVHc?oc=5","date":"2024-05-28","type":"pipeline","source":"Pharmaceutical Technology","summary":"J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase - Pharmaceutical Technology","headline":"J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQQWg0cVdDa3BDRmhNUlVLcmh6cnJJemtrbnctTHZmUVcyWmVEZFNsZjBIYVRLSW81MDBvRnB0U1hwQjRZNTVNRnNZMjV2dTNJcHBCWVdCQVg5ekVuZ3VsM1NSc1dRUlp1eWJCYnJqQzRkUGJJcW5fZGI1VFFTbkgxYmVNRWttMEthaXlzYjZ3bFVaMXdxQmJ4WE5hLTkxMTIzUmlqSnZR?oc=5","date":"2024-05-28","type":"deal","source":"BioCentury","summary":"J&J adds bispecific for atopic dermatitis via deal with Numab - BioCentury","headline":"J&J adds bispecific for atopic dermatitis via deal with Numab","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}